SCLX logo

Scilex Holding (SCLX) Company Overview

Profile

Full Name:

Scilex Holding Company

Sector:

Healthcare

Country:

United States

IPO:

March 5, 2021

Indexes:

Not included

Description:

Scilex Holding Company (SCLX) focuses on developing and commercializing innovative pain management solutions. The company aims to improve the quality of life for patients through advanced therapies, including non-opioid treatments, targeting various types of pain. Their goal is to provide safer and effective alternatives for pain relief.

Key Details

Price

$0.34

Annual Revenue

$46.74 M(+22.90% YoY)

Annual EPS

-$1.28(-652.94% YoY)

Beta

1.13

Events Calendar

Earnings

Next earnings date:

May 13, 2025

Recent quarterly earnings:

Jan 17, 2025

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Jan 27, 25 D. Boral Capital
Buy
Oct 21, 24 HC Wainwright & Co.
Buy
Oct 16, 24 Alliance Global Partners
Buy
Jun 17, 24 HC Wainwright & Co.
Buy
Jun 13, 24 Rodman & Renshaw
Buy
Jun 11, 24 HC Wainwright & Co.
Buy
May 23, 24 HC Wainwright & Co.
Buy
May 3, 24 HC Wainwright & Co.
Buy
Dec 4, 23 HC Wainwright & Co.
Buy
Oct 13, 23 B. Riley Securities
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Scilex Holding?
  • Does Scilex Holding pay dividends?
  • What sector is Scilex Holding in?
  • What industry is Scilex Holding in?
  • What country is Scilex Holding based in?
  • When did Scilex Holding go public?
  • Is Scilex Holding in the S&P 500?
  • Is Scilex Holding in the NASDAQ 100?
  • Is Scilex Holding in the Dow Jones?
  • When was Scilex Holding's last earnings report?
  • When does Scilex Holding report earnings?
  • Should I buy Scilex Holding stock now?

What is the ticker symbol for Scilex Holding?

The ticker symbol for Scilex Holding is NASDAQ:SCLX

Does Scilex Holding pay dividends?

No, Scilex Holding does not pay dividends

What sector is Scilex Holding in?

Scilex Holding is in the Healthcare sector

What industry is Scilex Holding in?

Scilex Holding is in the Drug Manufacturers - General industry

What country is Scilex Holding based in?

Scilex Holding is headquartered in United States

When did Scilex Holding go public?

Scilex Holding's initial public offering (IPO) was on March 5, 2021

Is Scilex Holding in the S&P 500?

No, Scilex Holding is not included in the S&P 500 index

Is Scilex Holding in the NASDAQ 100?

No, Scilex Holding is not included in the NASDAQ 100 index

Is Scilex Holding in the Dow Jones?

No, Scilex Holding is not included in the Dow Jones index

When was Scilex Holding's last earnings report?

Scilex Holding's most recent earnings report was on Jan 17, 2025

When does Scilex Holding report earnings?

The next expected earnings date for Scilex Holding is May 13, 2025

Should I buy Scilex Holding stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions